5 Patents
- US125761482026Engineered Immune Effector Cells for Cancer Immunotherapy That Are Resistant to Fratricide by Virtue of Having Genetically Modified Surface Antigens
Mitenyi Biotec B.V. & Co. Kg
0 cites - US123184462025Reducing Side Effects of Immunotherapy Using Genetically Modified Hematopoietic Cells
Miltenyi Biotec B.V. & Co. Kg
0 cites - US122460652025Immunotherapy of Cancer Patients Using CAR T or CAR NK Cells Combined with Hematopoietic Cells That Have a Modified or Deleted Target Antigen
Miltenyi Biotec B.V. & Co. Kg
0 cites - US118903002024Immune Cells Expressing an Antigen Binding Receptor and a Chimeric Costimulatory Receptor
Miltenyi Biotec B.V. & Co. KG
0 cites - US118834942024Combination of Immune Effector Cells Specific for a Target Antigen and Hematopoietic Calls That Express the Target Antigen in an Altered Form
MILTENYI BIOTEC B.V. & Co. KG
0 cites